VOYA Investment Management’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
13,589
+3,241
| +31% | +$48.5K | ﹤0.01% | 2321 |
|
|
2025
Q1 | $167K | Sell |
10,348
-147
| -1% | -$2.37K | ﹤0.01% | 2323 |
|
|
2024
Q4 | $244K | Sell |
10,495
-856
| -8% | -$19.9K | ﹤0.01% | 2301 |
|
|
2024
Q3 | $334K | Sell |
11,351
-256
| -2% | -$7.53K | ﹤0.01% | 2212 |
|
|
2024
Q2 | $273K | Buy |
+11,607
| New | +$273K | ﹤0.01% | 2298 |
|
|
2022
Q2 | – | Sell |
-15,466
| Closed | -$36K | – | 2886 |
|
|
2022
Q1 | $36K | Hold |
15,466
| – | – | ﹤0.01% | 2618 |
|
|
2021
Q4 | $73K | Sell |
15,466
-4,412
| -22% | -$20.8K | ﹤0.01% | 2708 |
|
|
2021
Q3 | $158K | Hold |
19,878
| – | – | ﹤0.01% | 2637 |
|
|
2021
Q2 | $138K | Sell |
19,878
-1,616
| -8% | -$11.2K | ﹤0.01% | 2697 |
|
|
2021
Q1 | $170K | Buy |
21,494
+3,750
| +21% | +$29.7K | ﹤0.01% | 2579 |
|
|
2020
Q4 | $140K | Buy |
17,744
+2,416
| +16% | +$19.1K | ﹤0.01% | 2503 |
|
|
2020
Q3 | $109K | Hold |
15,328
| – | – | ﹤0.01% | 2323 |
|
|
2020
Q2 | $142K | Buy |
15,328
+1,629
| +12% | +$15.1K | ﹤0.01% | 2266 |
|
|
2020
Q1 | $64K | Hold |
13,699
| – | – | ﹤0.01% | 2446 |
|
|
2019
Q4 | $105K | Buy |
+13,699
| New | +$105K | ﹤0.01% | 2536 |
|